Morbid obesity and type 2 diabetes alter intestinal fatty acid uptake and blood flow

Diabetes Obes Metab. 2018 Jun;20(6):1384-1390. doi: 10.1111/dom.13228. Epub 2018 Feb 11.

Abstract

Aims: Bariatric surgery is the most effective treatment to tackle morbid obesity and type 2 diabetes, but the mechanisms of action are still unclear. The objective of this study was to investigate the effects of bariatric surgery on intestinal fatty acid (FA) uptake and blood flow.

Materials and methods: We recruited 27 morbidly obese subjects, of whom 10 had type 2 diabetes and 15 were healthy age-matched controls. Intestinal blood flow and fatty acid uptake from circulation were measured during fasting state using positron emission tomography (PET). Obese subjects were re-studied 6 months after bariatric surgery. The mucosal location of intestinal FA retention was verified in insulin resistant mice with autoradiography.

Results: Compared to lean subjects, morbidly obese subjects had higher duodenal and jejunal FA uptake (P < .001) but similar intestinal blood flow (NS). Within 6 months after bariatric surgery, obese subjects had lost 24% of their weight and 7/10 diabetic subjects were in remission. Jejunal FA uptake was further increased (P < .03). Conversely, bariatric surgery provoked a decrease in jejunal blood flow (P < .05) while duodenal blood flow was preserved. Animal studies showed that FAs were taken up into enterocytes, for the most part, but were also transferred, in part, into the lumen.

Conclusions: In the obese, the small intestine actively takes up FAs from circulation and FA uptake remains higher than in controls post-operatively. Intestinal blood flow was not enhanced before or after bariatric surgery, suggesting that enhanced intestinal FA metabolism is not driven by intestinal perfusion.

Keywords: bariatric surgery; diabetes; free fatty acids; obesity; small intestine blood flow.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Validation Study

MeSH terms

  • Absorption, Physiological*
  • Adult
  • Animals
  • Bariatric Surgery
  • Body Mass Index
  • Diabetes Mellitus, Type 2 / blood
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / metabolism*
  • Diabetes Mellitus, Type 2 / therapy
  • Dietary Fats / metabolism
  • Fatty Acids, Nonesterified / blood
  • Fatty Acids, Nonesterified / metabolism*
  • Female
  • Fluorine Radioisotopes
  • Glucose Intolerance / blood
  • Glucose Intolerance / complications
  • Glucose Intolerance / metabolism
  • Glucose Intolerance / therapy
  • Humans
  • Insulin Resistance
  • Intestinal Absorption*
  • Intestinal Mucosa / blood supply
  • Intestinal Mucosa / diagnostic imaging
  • Intestinal Mucosa / metabolism*
  • Intestine, Small / blood supply
  • Intestine, Small / diagnostic imaging
  • Intestine, Small / metabolism*
  • Mice
  • Mice, Knockout
  • Middle Aged
  • Obesity, Morbid / complications
  • Obesity, Morbid / metabolism*
  • Obesity, Morbid / surgery
  • Obesity, Morbid / therapy
  • Positron-Emission Tomography
  • Regional Blood Flow
  • Weight Loss
  • Weight Reduction Programs

Substances

  • Dietary Fats
  • Fatty Acids, Nonesterified
  • Fluorine Radioisotopes